MEGAN GOETZ: Open Payments
NPI 1558837054 · VESTAVIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 32 payments from 13 companies in 2025. Trend: 2023 $1,177 · 2024 $1,238 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| Lilly USA, LLC | 2 | $47 |
| Amgen Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: QULIPTA, XIFAXAN, UBRELVY, VRAYLAR, LINZESS, AUSTEDO XR, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
